AUTHOR=Patella Vincenzo , Sanduzzi Alessandro , Bruzzese Dario , Florio Giovanni , Brancaccio Raffaele , Fabbrocini Gabriella , Delfino Gabriele 

TITLE=A Survey Among Italian Physicians During COVID-19 Outbreak. Could Bacillus Calmette–Guérin Vaccine Be Effective Against SARS-CoV2?

JOURNAL=Frontiers in Pharmacology

VOLUME=Volume 12 - 2021

YEAR=2021

URL=https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.646570

DOI=10.3389/fphar.2021.646570

ISSN=1663-9812

ABSTRACT=Background: Epidemiological studies show that BCG vaccinated population seems to be more likely protected from COVID-19 infection, but WHO gave a stark warning on use of BCG vaccine without confirmed COVID-19 trials. The aim of this survey is to assess the ability and readiness to respond to viral infection by physicians who had been BCG vaccinated.
Methods: After Ethical Committee authorization, professional orders were used to contact physicians with an online survey. Specialty, COVID-19 infection, and previous BCG vaccination were recorded. Statistical data analysis was performed.
Results: 1906 physicians answered the questionnaire, (M=1068; F=838; mean age 50.7+/-13.3; range 24 to 87 yrs), more than half (1062; 55.7 %) experienced BCG vaccination. Professional activity was recorded, and only 49 subjects (2.6%) of them were infected by SARS-CoV2. Among the group of infected people, asymptomatic form occurred in 12 subjects (24.5%); a pauci-symptomatic form in 24 subjects (49.0%); a severe form (pneumonia and/or respiratory distress) in 13 (26.5%). Considering only the clinically relevant form of COVID-19, period prevalence was 2.2% (23/1062) in vaccinated group and 1.7 % (14/844) in unvaccinated group (OR: 1.31, 95% C.I.: 0.68 to 2.63, p=0.427)
Conclusion: Our experience does not confirm the possible protective role of BCG vaccination, performed years earlier, against COVID-19. Although recent epidemiological studies point out in BCG vaccinated population a lower prevalence of SARS-CoV2 infection, in our cohort of physicians no significant difference was found in terms of prevalence of COVID-19 infection. Our data underline the necessity to follow the WHO warning about indiscriminate use of BCG vaccine, until clear evidence of protection by BCG vaccination against COVID-19 is fully demonstrated.